•
Jun 30, 2012

Arrowhead Pharmaceuticals Q3 2012 Earnings Report

Total Revenue
$47.9K
Previous year: $3.7M
-98.7%
EPS
-$0.73
Previous year: -$0.25
+192.0%
Gross Profit
$47.9K
0
Cash and Equivalents
$2.28M
Previous year: $4.32M
-47.1%
Total Assets
$16.5M
Previous year: $13.3M
+24.1%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals